Rahul Gaikwad, MD

NPI 1023375144ActiveIndividual· Internal Medicine, Infectious Disease· New York, NY

Internal Medicine, Infectious Disease (MD) in New York, New York, trained at University of Southern California Keck School of Medicine (class of 2012). 210 Medicare patients in 2024, $60,769 paid; nearly all of their 50 Part D prescriptions were generic (94%). Merck Sharp & Dohme LLC reported $87.29 in payments in 2025, mostly food and beverage.

Overview

NPI	1023375144
Status	Active
Entity type	Individual
Credential	MD
Sole proprietor	No
NPI issued	Apr 13, 2012
Last updated in NPPES	Sep 26, 2023
Certified by provider	Sep 26, 2023

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Infectious Disease Primary	207RI0200X	294251	NY
Hospitalist	208M00000X	294251	NY

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Oct 9, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026	No match	—
New York OMIG · Nov 4, 2026	No match	—
Ohio Medicaid · Nov 4, 2026	No match	—
Pennsylvania Medicheck · Nov 4, 2026	No match	—
Washington HCA · Nov 4, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Infectious Disease (NY)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	210
Services billed	613 across 7 procedure codes
Paid by Medicare	$60,769

Part D prescriptions in 2024

Prescriptions (claims)	50 · 70 30-day fills
Patients	16
Total drug cost	$28,686
Generic share	94% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Southern California Keck School of Medicine
Graduation year	2012
Medicare specialty	Infectious Disease
Secondary specialties	Hospitalist